Infectious Diseases Directory Resources

Add URL Infectious Diseases

Infectious Diseases News

Novel Microparticle Offers Immunological Breakthrough Against a Range . of Infectious Diseases and Potentially Some ... (InfoBolsa)

of Infectious Diseases and Potentially Some Cancers 15/05/2008 14:00:00 Business Wire When Virionyx, a New Zealand biotechnology company, tested a new anthrax vaccine, company scientists were elated when it worked, but then dumbfounded when one of the negative control agents compared to the vaccine also provided an unexpected level of protection against the bacterial toxin.

Disaster aftermath: The risk of epidemic diseases (CBC)

Natural disaster can kill hundreds of thousands of people a year. But the aftermath can keep on claiming lives. Outbreaks of infectious diseases following hurricanes, cyclones, tsunamis and earthquakes are not uncommon in the developing world. They are rare in developed countries. Most post-disaster disease is spawned by poor sanitation, a lack of safe drinking water and contaminated food.

Novel Microparticle Offers Immunological Breakthrough Against a Range of Infectious Diseases and Potentially Some ... (Centre Daily Times)

When Virionyx, a New Zealand biotechnology company, tested a new anthrax vaccine, company scientists were elated when it worked, but then dumbfounded when one of the negative control agents compared to the vaccine also provided an unexpected level of protection against the bacterial toxin. That finding has led rapidly to a breakthrough that could help protect against a wide range of infectious ...

Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, on HIV Vaccine ... (National Institutes of Health)

Twenty-five years ago this month, researchers reported the isolation of the virus that causes AIDS. Since then, over 60 million people have been infected with HIV — an estimated 2.5 million in 2007 alone — numbers that remind us that the development of an HIV vaccine is an urgent humanitarian imperative.

Biomerieux forms partnership to develop infectious disease tests (Sharewatch)

PARIS (Thomson Financial) - French diagnostics company Biomerieux has signed a partnership agreement with Swiss non-profit organisation the Foundation for Innovative New Diagnostics (FIND) to develop tests for infectious diseases, including tuberculosis.